ASTRO Journals

Send us Fan Mail

Sue Yom, Editor-in-Chief, co-hosts with Dr. Michelle Kim, Professor and Co-Chair of the Cancer Center's Neuro-Oncology Clinical Research Team at the University of Michigan, and our journal’s section lead for the CNS section. Our guests are Dr. Joshua Palmer, Associate Professor at Ohio State University and supervising author on the article, Dose/volume tolerance of the brain and predictors of radiation necrosis after three fraction radiosurgery for brain metastases: A large single-institutional analysis, and Dr. Arjun Sahgal, Chair and Professor at the Odette Cancer Centre of the Sunnybrook Health Sciences Centre, and supervising author on the article, Systematic Review Informing The Management of Symptomatic Brain Radiation Necrosis after Stereotactic Radiosurgery and International Stereotactic Radiosurgery Society (ISRS) Recommendations.

Send us Fan Mail

Editor-in-Chief Sue Yom hosts Dr. Karin Lindberg, a Clinical Oncologist at the Karolinska Institute in Sweden and the supervising author of a new paper this month, "Expanded HILUS trial - a pooled analysis of risk factors for toxicity from SBRT of central and ultra-central lung tumors," and Dr. David Palma, a Radiation Oncologist at the London Health Sciences Centre who co-authored the accompanying editorial, "Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultra-Central Thoracic Tumors?" Dr. Palma also describes the design and findings of the new clinical trial SUNSET, which he presented in the Multidisciplinary Thoracic Cancer Symposium plenary session simultaneously with this podcast release.

Send us Fan Mail

Editor-in-Chief Sue Yom co-hosts with Dr. Jean Wright, Breast Section Editor and Associate Professor of Radiation Oncology and Director of the radiation oncology Breast Cancer Program at Johns Hopkins University. Joining is Dr. Juliane Hörner-Rieber, Managing Senior Physician and Associate Professor at the Department of Radiation Oncology of Heidelberg University Hospital, who was supervising author of an article published this month, "Non-inferiority of Local Control and Comparable Toxicity of Intensity-modulated Radiotherapy With Simultaneous Integrated Boost in Breast Cancer: 5-year Results of the IMRT-MC2 Phase III Trial." Also joining is is Dr. Danielle Rodin, Associate Section Editor, radiation oncologist at Princess Margaret Cancer Centre, and Assistant Professor at the University of Toronto, who first-authored our Oncology Scan this month, "The Internal Mammary Node Irradiation Debate in Node-Positive Breast Cancer: Case Closed."

Send us Fan Mail

Editor-in-Chief, Robert Amdur, MD, explains how radiation oncologists are using ChatGPT and other Large Language Model programs in clinical practice. The discussion is based on a paper published in the November/December 2023 issue of PRO titled "Unlocking the Power of ChatGPT, Artificial Intelligence, and Large Language Models: Practical Suggestions for Radiation Oncologists" (2023, Issue 6, November/December, PMID: 37598727).

Send us Fan Mail

Dr. Sue Yom hosts Dr. Charles "Chuck" Mayo, Professor and Director of Radiation Oncology Informatics and Analytics at the University of Michigan and first author of an article in this month's issue, Operational Ontology for Oncology (O3) – A Professional Society-Based, Multi-Stakeholder, Consensus-Driven Informatics Standard Supporting Clinical and Research Use of "Real-World" Data from Patients Treated for Cancer, and Dr. Ying Xiao, Professor of Radiation Oncology at the University of Pennsylvania and supervising author of this same article, who also issued an accompanying explanatory editorial. Our group discusses the status and potential of oncology data standardization and its practical implementation through O3.

Send us Fan Mail

Editor-in-Chief Dr. Sue Yom is joined this month by co-host Dr. Danielle Margalit, the Red Journal's Head and Neck Section Editor and Associate Professor of Radiation Oncology at Harvard Medical School. Guests are Dr. Adam Garden, Professor of Radiation Oncology at UT MD Anderson Cancer Center, who is the first author of an article in this month's issue, "Final Report of NRG Oncology RTOG 0022: A Phase 1/2 Study of Conformal and Intensity Modulated Radiation for Oropharyngeal Cancer"; Dr. Michelle Echevarria, Assistant Member in the Department of Radiation Oncology at Moffitt Cancer Center and first author of another article printing this month, "Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck"; and Dr. Robert Chin, Associate Professor at UCLA Radiation Oncology and supervising author of a third article in the October issue, "High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial."

Send us Fan Mail

Practical Radiation Oncology associate editor Louis Potters, MD, of Northwell Health hosts a conversation on Treatment of Oligometastatic Non-Small Cell Lung Cancer: An ASTRO/ESTRO Clinical Practice Guideline. Two of the authors, Puneeth Iyengar MD, PhD of Memorial Sloan Kettering Cancer Center and Matthias Guckenberger MD of the University Hospital Zurich, along with patient advocate Jill Feldman discuss the framework for the treatment of oligo-mets of lung cancer.

Editor-in-Chief, Robert Amdur, MD, explains the main values used to evaluate conformality and dose gradient in treatment plans with high intensity hypofractionated dose schedules as are used in radiosurgery or stereotactic body radiotherapy. The basis for the discussion is a paper published in the September 2023 issue of PRO titled "Benchmarking Tests of Contemporary SRS Platforms: Have Technological Developments Resulted in Improved Treatment Plan Quality?" (2023, Issue 5, September/October, PMID: 37290672).

Send us Fan Mail

Editor-in-Chief Dr. Sue Yom hosts a discussion this month on audiovisual technology in the service of patients, along with Pediatrics/Sarcoma Section Editor Dr. Ralph Ermoian, Associate Professor in the Department of Radiation Oncology at the University of Washington School of Medicine. Joining the discussion are Dr. Susan Hiniker, Assistant Professor of Radiation Oncology at Stanford University, who is the supervising author of an article in this month’s issue, Feasibility of the Audio-Visual Assisted Therapeutic Ambience in Radiotherapy (AVATAR) System for Anesthesia Avoidance in Pediatric Patients: A Multicenter Trial. We also welcome Dr. Jee Suk Chang, Assistant Professor at Yonsei University in Korea, currently on sabbatical at BC Cancer in Vancouver, who is (co) first author on an article in press that has just issued online, An Investigation of the Impact of Virtual Reality on Alleviating Anxiety in Patients with Breast Cancer Undergoing Radiotherapy: A Randomized Controlled Trial.

Editor-in-Chief, Robert Amdur, MD, discusses misinformation about cancer treatment. The discussion is based on a paper published in the July 2023 issue of PRO titled “Identifying Cancer Treatment Misinformation and Strategies to Mitigate Its Effects With Improved Radiation Oncologist−Patient Communication" (2023, Issue 4, July/August, PMID: 36736620).